Jafron BiomedicalLtd Dividend
Dividend criteria checks 3/6
Jafron BiomedicalLtd is a dividend paying company with a current yield of 1.64% that is well covered by earnings.
Key information
1.6%
Dividend yield
45%
Payout ratio
| Industry average yield | 1.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.400 |
| Earnings per share | CN¥0.92 |
| Dividend yield forecast | 4.0% |
Recent dividend updates
Recent updates
Estimating The Fair Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)
Sep 09
The Returns On Capital At Jafron BiomedicalLtd (SZSE:300529) Don't Inspire Confidence
Aug 25Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40
May 28A Look At The Intrinsic Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)
May 24Why Investors Shouldn't Be Surprised By Jafron Biomedical Co.,Ltd.'s (SZSE:300529) 30% Share Price Surge
May 08Jafron BiomedicalLtd's (SZSE:300529) Soft Earnings Don't Show The Whole Picture
May 02Investors Could Be Concerned With Jafron BiomedicalLtd's (SZSE:300529) Returns On Capital
Apr 13Does Jafron BiomedicalLtd (SZSE:300529) Have A Healthy Balance Sheet?
Mar 22Jafron Biomedical Co.,Ltd.'s (SZSE:300529) P/E Is Still On The Mark Following 31% Share Price Bounce
Mar 04Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300529 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 300529's dividend payments have increased, but the company has only paid a dividend for 7 years.
Dividend Yield vs Market
| Jafron BiomedicalLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300529) | 1.6% |
| Market Bottom 25% (CN) | 0.8% |
| Market Top 25% (CN) | 2.8% |
| Industry Average (Medical Equipment) | 1.8% |
| Analyst forecast (300529) (up to 3 years) | 4.0% |
Notable Dividend: 300529's dividend (1.64%) is higher than the bottom 25% of dividend payers in the CN market (0.75%).
High Dividend: 300529's dividend (1.64%) is low compared to the top 25% of dividend payers in the CN market (2.75%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (44.8%), 300529's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (33.4%), 300529's dividend payments are well covered by cash flows.